中华皮肤科杂志 ›› 2016, Vol. 49 ›› Issue (1): 21-25.

• 论著 • 上一篇    下一篇

梅毒螺旋体膜蛋白Tpp47通过RhoA/ROCK信号通路调控血管内皮细胞通透性

张瑞丽1,王千秋2   

  1. 1. 南京医科大学附属无锡二院
    2. 南京 中国医学科学院北京协和医学院皮肤病研究所
  • 收稿日期:2015-04-24 修回日期:2015-08-26 出版日期:2016-01-15 发布日期:2015-12-31
  • 通讯作者: 王千秋 E-mail:doctorwqq@163.com
  • 基金资助:

    江苏省自然科学基金面上项目

Treponema pallidum membrane protein Tpp47 regulates the permeability of vascular endothelial cells via the RhoA/ROCK signal pathway: an experimental study

1,   

  • Received:2015-04-24 Revised:2015-08-26 Online:2016-01-15 Published:2015-12-31

摘要:

目的 探讨梅毒螺旋体膜重组蛋白Tpp47对血管内皮细胞通透性影响的调控机制。 方法 用人脐静脉内皮细胞(HUVEC)构建细胞单层模型,重组蛋白Tpp47(rTpp47)直接与HUVEC单层模型混合培养,或RhoA/ROCK信号通路特异性抑制剂Y-27632预处理后再用rTpp47刺激HUVEC单层模型,以煮沸灭活的rTpp47处理HUVEC单层模型为阴性对照组,采用ELISA检测各组培养1、4 h时辣根过氧化物酶(HRP)流量,培养12 h用荧光染料罗丹明-鬼笔环肽染色细胞骨架系统,共聚焦显微镜下观察细胞骨架蛋白F肌动蛋白排列变化。用Western 印迹检测rTpp47与煮沸灭活的rTpp47分别处理HUVEC单层模型后细胞RhoA的表达水平。 结果 rTpp47刺激HUVEC单层模型1 h时HRP流量(0.81 ± 0.10)高于阴性对照组(0.39 ± 0.09),差异有统计学意义(P < 0.05),而此时Y-27632预处理组HRP流量(0.51 ± 0.10)与单用rTpp47刺激组及阴性对照组相比,差异无统计学意义(均P > 0.05)。培养4 h时,单用rTpp47刺激组HRP流量显著增加(2.31 ± 0.14),且高于Y-27632预处理组(1.21 ± 0.12)及阴性对照组(0.73 ± 0.12),差异有统计学意义(均P < 0.05),而Y-27632预处理组与阴性对照组之间差异无统计学意义。rTpp47刺激HUVEC后,与煮沸灭活的rTpp47作用HUVEC相比,细胞中RhoA表达增加。同时,rTpp47刺激细胞中骨架蛋白F肌动蛋白重排,在胞质中形成应力纤维,抑制剂Y-27632可部分抑制F肌动蛋白重排。 结论 梅毒螺旋体膜重组蛋白Tpp47可通过RhoA/ROCK信号转导通路调控血管内皮细胞通透性。

Abstract:

Zhang Ruili, Wang Qianqiu Department of Dermatology, Wuxi No.2 People′s Hospital, Wuxi 214002, Jiangsu, China (Zhang R); Department of Sexually Transmitted Disease Clinical Management, Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing 210042, China (Wang QQ) Corresponding author: Wang Qianqiu, Email: doctorwqq@163.com 【Abstract】 Objective To investigate mechanisms underlying the regulation of the permeability of vascular endothelial cells by the Treponema pallidum membrane protein Tpp47. Methods Human umbilical vascular endothelial cell (HUVEC) monolayers were established as a model, and were directly cultured with the presence of recombinant Tpp47 protein (rTpp47-treated group), or boiled and inactivated rTpp47 (negative control group). Some HUVEC monolayers, which were pretreated with the RhoA/ROCK signal pathway inhibitor Y-27632 for 30 minutes and then cultured with the presence of rTpp47, served as the pretreatment group. After 1- and 4-hour additional culture, enzyme-linked immunosorbent assay (ELISA) was performed to estimate the permeability of these cell monolayers to horseradish peroxidase (HRP). After 12 hours of culture, rhodamine-phalloidin was used to stain cytoskeletal proteins, and confocal laser scanning microscopy was performed to observe the arrangement of the cytoskeletal protein F-actin. Western-blot analysis was conducted to measure the expressions of RhoA in HUVECs treated with rTpp47 or inactivated rTpp47. Results The supernatant level of HRP (expressed as the absorbance value at 450 nm) was significantly higher in the rTpp47-treated group than in the negative control group (0.81 ± 0.10 vs. 0.39 ± 0.09, P < 0.05), but no significant difference was observed between the pretreatment group (0.51 ± 0.10) and rTpp47-treated group or negative control group (both P > 0.05) after 1-hour culture. Similarly, the rTpp47-treated group showed significantly increased levels of HRP compared with the pretreatment group and negative control group (2.31 ± 0.14 vs. 1.21 ± 0.12 and 0.73 ± 0.12, both P < 0.05), while there was no significant difference between the pretreatment group and negative control group after 4-hour culture. The expression of RhoA in HUVECs treated with rTpp47 was significantly higher than that in those treated with inactivated rTpp47. Confocal laser scanning microscopy showed that rTpp47 treatment led to the rearrangement of F-actin in HUVECs followed by the formation of stress fibers in cytoplasm, while Y-27632 could partly inhibit the rearrangement of F-actin. Conclusion The recombinant Treponema pallidum membrane protein Tpp47 can regulate the permeability of vascular endothelial cells through the RhoA/ROCK signal pathway.